West Pharmaceutical Services | WST - Ebitda

Aktienkurs
292.13
Täglich Wechseln
-10.07 -3.33%
Monatlich
19.17%
Jährlich
36.85%
Q2 Prognose
299.61




Ebitda Veränderung Datum
Align Technology USD 183.84M 19.77M 2025-09
Avanos Medical USD 10M 73.9M 2025-09
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dentsply International USD 135M 32M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
ICU Medical USD 98.19M 27.67M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
J&J USD 7.19B 2.32B 2025-12
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Neogen USD 48.2M 546K 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Quidel USD 153.3M 23.8M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Solventum Corp USD 437M 38M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12
Terumo JPY 69.99B 3.22B 2025-12
West Pharmaceutical Services USD 226.2M 7.7M 2026-03